» Articles » PMID: 39224639

Nanomaterials: Innovative Approaches for Addressing Key Objectives in Periodontitis Treatment

Overview
Journal RSC Adv
Specialty Chemistry
Date 2024 Sep 3
PMID 39224639
Authors
Affiliations
Soon will be listed here.
Abstract

Periodontitis is a chronic inflammatory disease primarily caused by dental plaque, which is a significant global public health concern due to its high prevalence and severe impact on oral, and even systemic diseases. The current therapeutic plan focuses on three objectives: pathogenic bacteria inhibition, inflammation control, and osteogenic differentiation induction. Existing treatments still have plenty of drawbacks, thus, there is a pressing need for novel methods to achieve more effective treatment effects. Nanomaterials, as emerging materials, have been proven to exert their inherent biological properties or serve as stable drug delivery platforms, which may offer innovative solutions in periodontitis treatment. Nanomaterials utilized in periodontitis treatment fall into two categories, organic and inorganic nanomaterials. Organic nanomaterials are known for their biocompatibility and their potential to promote tissue regeneration and cell functions, including natural and synthetic polymers. Inorganic nanomaterials, such as metal, oxides, and mesoporous silica nanoparticles, exhibit unique physicochemical properties that make them suitable as antibacterial agents and drug delivery platforms. The inorganic nanosurface provides terrain induction for cell migration and osteogenic regeneration at defect sites by introducing different surface morphologies. Inorganic nanomaterials also play a role in antibacterial photodynamic therapy (aPDT) for eliminating pathogenic bacteria in the oral cavity. In this review, we will introduce multiple forms and applications of nanomaterials in periodontitis treatment and focus on their roles in addressing the key therapeutic objectives, to emphasize their promising future in achieving more effective and patient-friendly approaches toward periodontal tissue regeneration and overall health.

Citing Articles

How Will Nanomedicine Revolutionize Future Dentistry and Periodontal Therapy?.

DAmico E, Aceto G, Petrini M, Cinquini C, DErcole S, Iezzi G Int J Mol Sci. 2025; 26(2).

PMID: 39859308 PMC: 11765319. DOI: 10.3390/ijms26020592.

References
1.
Andersson D, Hughes D, Kubicek-Sutherland J . Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat. 2016; 26:43-57. DOI: 10.1016/j.drup.2016.04.002. View

2.
Bhattarai G, Poudel S, Kook S, Lee J . Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 2015; 29:398-408. DOI: 10.1016/j.actbio.2015.10.031. View

3.
Liao W, Yang D, Xu Z, Zhao L, Mu C, Li D . Antibacterial Collagen-Based Nanocomposite Dressings for Promoting Infected Wound Healing. Adv Healthc Mater. 2023; 12(15):e2203054. DOI: 10.1002/adhm.202203054. View

4.
Fong D, Hoemann C . Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage. Future Sci OA. 2017; 4(1):FSO225. PMC: 5729595. DOI: 10.4155/fsoa-2017-0064. View

5.
Chen M, Zhong Y, Dong Q, Wong H, Wen Y . Global, regional, and national burden of severe periodontitis, 1990-2019: An analysis of the Global Burden of Disease Study 2019. J Clin Periodontol. 2021; 48(9):1165-1188. DOI: 10.1111/jcpe.13506. View